Home NDC 68382-483 pitavastatin calcium
Product NDC 68382-483
11-digit product format 683820483
Labeler code 68382
Product ID 68382-483_f34ff300-0613-4b94-9fcf-475d6494ea7e
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name pitavastatin calcium
Dosage form TABLET
Route ORAL
Labeler Zydus Pharmaceuticals USA Inc.
Application ANDA206047
Marketing category ANDA
Marketing start 2023-11-02
Substance PITAVASTATIN CALCIUM
Active strength 4 mg/1
Pharmacologic classes HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A206047-001 PITAVASTATIN CALCIUM PITAVASTATIN CALCIUM EQ 1MG BASE TABLET / ORAL AB 2023-02-22 A206047-002 PITAVASTATIN CALCIUM PITAVASTATIN CALCIUM EQ 2MG BASE TABLET / ORAL AB 2023-02-22 A206047-003 PITAVASTATIN CALCIUM PITAVASTATIN CALCIUM EQ 4MG BASE TABLET / ORAL AB 2023-02-22
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-01 22:54:32 2026-06 A206047-001 PITAVASTATIN CALCIUM EQ 1MG BASE TABLET / ORAL AB 2023-02-22 a50c72e98297…2026-08-01 22:54:32 2026-06 A206047-002 PITAVASTATIN CALCIUM EQ 2MG BASE TABLET / ORAL AB 2023-02-22 a50c72e98297…2026-08-01 22:54:32 2026-06 A206047-003 PITAVASTATIN CALCIUM EQ 4MG BASE TABLET / ORAL AB 2023-02-22 a50c72e98297…
Observed Orange Book normalized TE history# openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Additional Listing Data#
Finished product Yes
Brand name base pitavastatin calcium
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength PITAVASTATIN CALCIUM 4 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination IYD54XEG3W Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 861643 Internal RxNorm lookup 861648 Internal RxNorm lookup 861652 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 68382-483-16 pitavastatin calcium 90 in 1 BOTTLE TABLET 90 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 68382-483 PITAVASTATIN CALCIUM TABLET [ZYDUS PHARMACEUTICALS USA INC.] 5 Current NDC, 1 package rows 20240329_c35e747e-10ac-4a76-bce6-187618fc64f9.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 68382-483-16 68382048316 90 TABLET in 1 BOTTLE (68382-483-16) 90 tablet 2023-11-02 No No Current